ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,288Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 1844

$1.38M Total Retail Price of All Prescriptions

Rank: 17 out of 1844

518 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 518 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 518 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 19,442 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 974 855 1 7
LEVOTHYROXINE SODIUM 840 698 2 1
OMEPRAZOLE 754 586 3 5
HYDROCODONE-ACETAMINOPHEN 673 517 S3 4 2
LISINOPRIL 656 514 5 4
POTASSIUM CHLORIDE 628 528 6 16
GABAPENTIN 583 455 7 15
WARFARIN SODIUM 482 432 8 13
NAMENDA 441 414 9 33
METOPROLOL TARTRATE 405 343 10 11
AMLODIPINE BESYLATE 405 344 10 6
CITALOPRAM HBR 391 322 12 19
SIMVASTATIN 370 296 13 3
METFORMIN HCL 352 286 14 8
DONEPEZIL HCL 347 325 15 26
FAMOTIDINE 330 298 16 63
TRAZODONE HCL 323 240 17 43
PRAVASTATIN SODIUM 299 249 18 10
METOPROLOL SUCCINATE 288 242 19 14
MIRTAZAPINE 287 268 20 49
SPIRIVA 274 205 21 57
LANTUS 260 233 22 42
POLYETHYLENE GLYCOL 3350 235 161 23 39
CYMBALTA 223 179 24 36
GLIMEPIRIDE 209 174 25 35
FENTANYL 194 173 S2 26 66
CARVEDILOL 191 169 27 22
SERTRALINE HCL 190 157 28 21
LOSARTAN POTASSIUM 188 169 29 24
ATENOLOL 183 160 30 17
DIVALPROEX SODIUM 178 129 31 74
LEVOFLOXACIN 175 158 32 78
ATORVASTATIN CALCIUM 174 124 33 12
ISOSORBIDE MONONITRATE ER 171 158 34 59
ALLOPURINOL 151 149 35 29
TRAMADOL HCL 149 118 36 18
SUCRALFATE 143 115 37 183
ALBUTEROL SULFATE 142 141 38 115
HYDROCHLOROTHIAZIDE 142 90 38 9
NOVOLOG 141 133 40 84
ROPINIROLE HCL 138 131 41 76
CLOPIDOGREL 132 121 42 34
BENAZEPRIL HCL 129 89 43 75
MELOXICAM 128 103 44 28
ALENDRONATE SODIUM 126 98 45 25
CRESTOR 124 69 46 30
TAMSULOSIN HCL 123 104 47 27
CEPHALEXIN 120 96 48 56
SULFAMETHOXAZOLE-TRIMETHOPRIM 119 84 49 73
METOCLOPRAMIDE HCL 116 91 50 148
LEVETIRACETAM 116 85 50 105
AMOX TR-POTASSIUM CLAVULANATE 115 91 52 139
PROMETHAZINE HCL 113 74 R 53 88
GEMFIBROZIL 113 89 53 108
ZOLPIDEM TARTRATE 112 73 55 23
CIPROFLOXACIN HCL 108 94 56 62
ADVAIR DISKUS 107 97 57 51
PLAVIX 106 95 58 61
DOXAZOSIN MESYLATE 105 96 59 110
CEFTRIAXONE 105 94 59 213
AMOXICILLIN 105 73 59 101
LOVASTATIN 104 91 62 44
QUETIAPINE FUMARATE 103 70 63 82
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 89 63 20
DILTIAZEM 24HR CD 103 85 63 132
OXYBUTYNIN CHLORIDE ER 103 81 63 126
PROPRANOLOL HCL 102 82 67 129
MORPHINE SULFATE ER 100 60 S2 68 107
BACLOFEN 99 48 69 119
HUMALOG 98 74 70 114
PANTOPRAZOLE SODIUM 97 57 71 32
BUSPIRONE HCL 93 47 72 127
NAPROXEN 92 84 73 87
RANITIDINE HCL 90 66 74 38
MORPHINE SULFATE 89 72 S2 75 207
ESCITALOPRAM OXALATE 89 67 75 52
TRIAMCINOLONE ACETONIDE 89 68 75 153
CEFDINIR 86 69 78 169
OXYCODONE HCL-ACETAMINOPHEN 86 52 S2 78 83
RISPERIDONE 85 82 80 65
PREDNISONE 80 49 81 40
NEXIUM 79 76 82 31
NYSTATIN 78 70 83 85
CARBIDOPA-LEVODOPA 77 77 84 86
LEVEMIR 74 63 85 157
BUPROPION HCL SR 72 38 86 196
PHENYTOIN SODIUM EXTENDED 71 25 87 147
FLUOXETINE HCL 71 31 87 41
KLOR-CON M10 71 71 87 149
PAROXETINE HCL 70 70 90 68
DIOVAN 70 70 90 58
CARBAMAZEPINE 68 53 92 204
PRIMIDONE 67 50 93 289
DIGOXIN 67 36 93 67
HYDROXYZINE HCL 67 37 R 93 164
MECLIZINE HCL 64 60 96 142
CEFUROXIME 64 58 96 184
ZETIA 64 23 96 81
LIDOCAINE HCL 63 57 99 270
JANUVIA 63 49 99 77
PROAIR HFA 62 36 101 45
OLANZAPINE 61 50 102 117
FLUTICASONE PROPIONATE 60 47 103 50
NOVOLOG FLEXPEN 59 31 104 163
GLIPIZIDE 59 57 104 70
CLONIDINE HCL 57 33 106 64
KLOR-CON M20 56 56 107 54
TOPIRAMATE 55 16 108 165
ALPRAZOLAM 54 40 109 124
LYRICA 53 42 110 92
SPIRONOLACTONE 51 43 111 60
ABILIFY 51 28 111 150
FENOFIBRATE 50 50 113 71
GLYBURIDE-METFORMIN HCL 50 39 R 113 140
VYTORIN 50 41 113 211
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.